Navigation Links
Micromet Announces Pricing of Public Offering of Common Stock
Date:7/30/2009

tes that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborators, including MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009, filed with the SEC on May 11, 2009, as well as other filings by the company with the SEC.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... September 12, 2014 Advancing the ... decontamination of chemical and biological threats is the ... Worcester Polytechnic Institute (WPI) and the Georgian National ... Science for Peace and Security Programme of the ... NATO’s Advanced Research Workshop series, the event is ...
(Date:9/12/2014)... Sandia Biotech, Inc. announced today that ... STC.UNM (STC) for a technology developed by researchers at ... Mexico, and Queen Mary University of London in London, ... Fluorescent Antibody Technology Platform (RFAP) was developed by Dr. ... Dr. Angray Kang from Queen Mary’s Department of Molecular ...
(Date:9/11/2014)... are first to show the use of sound to ... phenomena from quantum physics with sound taking on the ... the journal Science . , The interaction between ... studied extensively in the field of quantum optics. However, ... waves has been a more challenging undertaking. The Chalmers ...
(Date:9/11/2014)... , Sept. 11, 2014  Lakewood-Amedex ... pharmaceuticals, announced today that the United States ... ,Notice of Allowance, for patent application 11/673,486 ...  The ,486 patent application relates to the ... gene-silencing and can be designed to treat ...
Breaking Biology Technology:Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4The sound of an atom has been captured 2Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 2Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 3
... Sept. 1 Mylan Inc. (Nasdaq: MYL ... CEO of Trident USA Health Services, the nation,s largest ... long-term care industry, has joined Mylan,s Board of Directors. ... also is president of the International Federation of Pharmaceutical ...
... Sept. 1 /PRNewswire-FirstCall/ - avVaa World Health Care Products ... and distributor of nationally branded therapeutic, natural skin and ... its first week of DRTV 120/60 second test commercials ... COO of avVaa World Health Care Products Inc. stated, ...
... CITY, Sept. 1 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on endocrine therapy and oncology, ... Medical Officer, Paul Blake, M.D., will present a corporate ... Global Investment Conference on Wednesday, September 9, 2009 at ...
Cached Biology Technology:Mark W. Parrish Joins Mylan's Board of Directors 2avVaa World Health Care Products, Inc. Announces the completion of its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief 2
(Date:9/12/2014)... College of New York biologist Mike Hickerson, a team of ... how so many species of birds ended up in the ... to the southernmost tip of South America. It is home ... question has beenhow did this extraordinary bird diversity originate?" said ... subject published in the journal Nature this week ...
(Date:9/12/2014)... cartilage plays an active role in the destruction ... rather than being an ,innocent bystander, as previously ... Dr Kate Lawler, Dr Ben Croker and colleagues ... the discovery while investigating the role of the ... The study was published in the journal ...
(Date:9/11/2014)... The classical treatise "Flora of Northumberland and Durham" ... Advanced Books platform as an example of ... create a new sort of resource and data re-use. ... botany of the region, which can be seen as ... on-line semantically enriched re-publication marries the meticulous detail ...
Breaking Biology News(10 mins):No innocent bystander: Cartilage contributes to arthritis 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 3
... Discovery Fund (LSDF) today announced $1.1 million in ... and non-profit organizations to foster the translation of ... marketplace. Two of the five new ... invented within Washington-based companies. HeatFlow Technologies (principal investigator ...
... Researchers at Queen Mary University of London have shown for ... on to perform is controlled by primary cilia tiny hair-like ... of becoming any cell type within the body through the ... for application in the development of new therapies for a ...
... has known for years that people who drink moderate amounts ... general, they are healthier and have better cardiovascular function that ... research from Oregon Health & Science University adds a fascinating ... help it fight off infection. The research, published Dec. ...
Cached Biology News:Life Sciences Discovery Fund announces R&D grants 2Study: Moderate alcohol consumption boosts body's immune system 2Study: Moderate alcohol consumption boosts body's immune system 3
... 'Agilents GeneSpring Workgroup solution is ... managing and mining expression data in ... and is deployed in over 40 ... research organizations worldwide. GeneSpring Workgroup streamlines ...
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... a genome-wide microRNA (miRNA) expression profiling service ... which enable highly sensitive and specific direct ... arrays for mature miRNA of all species ... Sanger miRBase database (Release 8.2). Our service ...
... PEP-165 is an 18 amino acid synthetic peptide whose sequences are ... is (amino to carboxy terminus): S(21) - S - M - ... - E - A - I - D - K - ... This peptide may be used for neutralization and control ...
Biology Products: